{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:56:25Z","timestamp":1781643385533,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early and accurate detection of inflammatory activity is essential in inflammatory arthropathies, as timely treatment can prevent irreversible joint damage. Optical spectral transmission (OST), implemented in the HandScan device, is a novel, non-invasive imaging method that uses red and near-infrared light to detect perfusion changes associated with angiogenesis and hypervascularity in inflamed joints. This review summarizes current evidence on OST, assessing its diagnostic performance and clinical utility relative to musculoskeletal ultrasound, magnetic resonance imaging, and conventional clinical activity indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Relevant studies were identified through systematic searches of the Web of Science and PubMed databases, with the last search conducted on October 7, 2025, according to predefined inclusion criteria. Publications from 2012 to 2025 were considered eligible. Studies enrolling patients with rheumatic diseases were included, and data were extracted on study population characteristics, methodologies, and main findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 77 studies screened, 22 met the inclusion criteria. Cross-sectional studies showed significant correlations between OST and ultrasound findings, with areas under the curve (AUC) reaching as high as 0.85. This correlation was particularly strong in the metacarpophalangeal and proximal interphalangeal joints. Additionally, OST correlated with MRI-detected synovitis and tenosynovitis but not with bone marrow edema. Moderate associations were observed between OST and clinical indicators such as DAS28, swollen joint counts, and C-reactive protein levels. Longitudinal analyses revealed significant associations between changes in OST values and changes in clinical activity indices, specifically \u0394DAS28, and \u0394SJC. However, it was found that absolute OST scores alone were inadequate for distinguishing between different levels of disease activity. Factors such as sex, body mass index, and structural joint damage were identified as confounding variables that influenced the measurements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>OST is a promising, rapid, and operator-independent technique for quantifying joint inflammation in rheumatoid arthritis. Although further evaluation of its stand-alone diagnostic accuracy is needed, its integration with clinical assessment and imaging may enhance the objectivity and efficiency of disease monitoring. Standardized measurement protocols and patient-adjusted thresholds will be essential for broader clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-026-00635-x","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:04:31Z","timestamp":1773824671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing disease activity in inflammatory arthritis using optical spectral transmission: a systematic review compared to joint ultrasound, MRI, and clinical activity markers"],"prefix":"10.1186","volume":"10","author":[{"given":"Ann-Kathrin","family":"Druck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Keshavamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alhaddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas V.","family":"Goules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schwarting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Triantafyllias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"635_CR1","doi-asserted-by":"publisher","unstructured":"Ramiro S, Radner H, van der Heijde D, van Tubergen A, Buchbinder R, Aletaha D, et al. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev. 2011;2011(10):Cd008886. Epub 20111005. https:\/\/doi.org\/10.1002\/14651858.CD008886.pub2. PubMed PMID: 21975788; PubMed Central PMCID: PMC12416524.","DOI":"10.1002\/14651858.CD008886.pub2"},{"key":"635_CR2","doi-asserted-by":"publisher","unstructured":"Iwaszko M, Bia\u0142y S, Bogunia-Kubik K. Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis. Cells. 2021;10(11). Epub 20211103. https:\/\/doi.org\/10.3390\/cells10113000. PubMed PMID: 34831223; PubMed Central PMCID: PMC8616130.","DOI":"10.3390\/cells10113000"},{"key":"635_CR3","first-page":"5","volume":"Spec No","author":"MJ Bergman","year":"2006","unstructured":"Bergman MJ. Social and economic impact of inflammatory arthritis. Postgrad Med. 2006;Spec No:5\u201311. PubMed PMID: 17960689.","journal-title":"Postgrad Med"},{"key":"635_CR4","doi-asserted-by":"publisher","unstructured":"Triantafyllias K, Thiele LE, Cavagna L, Baraliakos X, Bertsias G, Schwarting A. Arterial stiffness as a surrogate marker of cardiovascular disease and atherosclerosis in patients with arthritides and connective tissue diseases: a literature review. Diagnostics (Basel). 2023;13(11). Epub 20230526. https:\/\/doi.org\/10.3390\/diagnostics13111870. PubMed PMID: 37296720; PubMed Central PMCID: PMC10252997.","DOI":"10.3390\/diagnostics13111870"},{"key":"635_CR5","doi-asserted-by":"publisher","first-page":"820263","DOI":"10.3389\/fmed.2022.820263","volume":"9","author":"A Mandel","year":"2022","unstructured":"Mandel A, Schwarting A, Cavagna L, Triantafyllias K. Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future. Front Med (Lausanne). 2022;9:820263. https:\/\/doi.org\/10.3389\/fmed.2022.820263. Epub 20220630.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"635_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00393-019-0596-9","volume":"78","author":"K Triantafyllias","year":"2019","unstructured":"Triantafyllias K, Lei\u00df R, Dreher M, Schwarting A. [Depressive symptoms in early rheumatoid arthritis: Within the rheumatism network ADAPTHERA]. Z Rheumatol. 2019;78(7):670\u20136. https:\/\/doi.org\/10.1007\/s00393-019-0596-9. PubMed PMID: 31016369.","journal-title":"Z Rheumatol"},{"issue":"2","key":"635_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/ard-2023-224205","volume":"83","author":"M Dreher","year":"2024","unstructured":"Dreher M, Witte T, Hoeper K, Assmann G, Proft F, Poddubnyy D, et al. Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres. Ann Rheum Dis. 2024;83(2):184\u201393. https:\/\/doi.org\/10.1136\/ard-2023-224205. Epub 20240111.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"635_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00393-019-0653-4","volume":"78","author":"A Lauter","year":"2019","unstructured":"Lauter A, Triantafyllias K, Lei\u00df R, Amberger C, Engels J, Hesse M, et al. [ADAPTHERA-Statewide cross-sectoral care network for patients with early rheumatoid arthritis shows sustained remission in standard care]. Z Rheumatol. 2019;78(7):660\u20139. https:\/\/doi.org\/10.1007\/s00393-019-0653-4. PubMed PMID: 31165251.","journal-title":"Z Rheumatol"},{"key":"635_CR9","doi-asserted-by":"publisher","first-page":"565275","DOI":"10.3389\/fimmu.2020.565275","volume":"11","author":"X Wu","year":"2020","unstructured":"Wu X. Innate Lymphocytes in Inflammatory Arthritis. Front Immunol. 2020;11:565275. Epub 20200925. doi: 10.3389\/fimmu.2020.565275. PubMed PMID: 33072104; PubMed Central PMCID: PMC7544949.","journal-title":"Front Immunol"},{"key":"635_CR10","doi-asserted-by":"publisher","first-page":"152465","DOI":"10.1016\/j.semarthrit.2024.152465","volume":"67","author":"Y Hao","year":"2024","unstructured":"Hao Y, Oon S, Nikpour M. Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis. Semin Arthritis Rheum. 2024;67:152465. https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152465. Epub 20240521.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"635_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685\u201399. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216655. Epub 20200122.","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 85","key":"635_CR12","first-page":"S","volume":"32","author":"PL van Riel","year":"2014","unstructured":"van Riel PL. The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). Clin Exp Rheumatol. 2014;32(5 Suppl 85):S\u201365. Epub 20141030. PubMed PMID: 25365092.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"635_CR13","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3899\/jrheum.090881","volume":"37","author":"S JOUSSE-JOULIN","year":"2010","unstructured":"Jousse-Joulin S, d\u2019Agostino MA, Marhadour T, Albert JD, Bentin J, Chary Valckenaere I, et al. Reproducibility of joint swelling assessment by sonography in patients with long-lasting rheumatoid arthritis (SEA-Repro Study Part II). J Rhuematol. 2010;37(5):938\u201345. https:\/\/doi.org\/10.3899\/jrheum.090881.","journal-title":"J Rhuematol"},{"issue":"1","key":"635_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13075-023-03023-9","volume":"25","author":"K Triantafyllias","year":"2023","unstructured":"Triantafyllias K, Marinoska T, Heller C, de Blasi M, Muthuraman M, Schwarting A. Optical spectral transmission to assess glucocorticoid therapy response in patients with arthritis: a longitudinal follow-up comparison with joint ultrasound. Arthritis Res Ther. 2023;25(1):47. https:\/\/doi.org\/10.1186\/s13075-023-03023-9. Epub 20230325.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"635_CR15","first-page":"831","volume":"33","author":"SC Nair","year":"2015","unstructured":"Nair SC, Welsing PM, Jacobs JW, van Laar JM, Rensen WH, Ardine de Wit G, et al. Economic evaluation of a tight-control treatment strategy using an imaging device (handscan) for monitoring joint inflammation in early rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(6):831\u20138. Epub 20150907. PubMed PMID: 26343274.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"635_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/ar794","volume":"5","author":"PC Taylor","year":"2003","unstructured":"Taylor PC. The value of sensitive imaging modalities in rheumatoid arthritis. Arthritis Res Ther. 2003;5(5):210. https:\/\/doi.org\/10.1186\/ar794.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"635_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/rheumatology\/kex531","volume":"57","author":"NJ Besselink","year":"2018","unstructured":"Besselink NJ, van der Meijde P, Rensen WHJ, Meijer PBL, Marijnissen ACA, van Laar JM, et al. Optical spectral transmission to assess inflammation in hand and wrist joints of rheumatoid arthritis patients. Rheumatology (Oxford). 2018;57(5):865\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/kex531. PubMed PMID: 29471516.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"635_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.berh.2004.08.006","volume":"19","author":"M \u00d8stergaard","year":"2005","unstructured":"\u00d8stergaard M, Ejbjerg B, Szkudlarek M. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheumatol. 2005;19(1):91\u2013116. 006. PubMed PMID: 15588973.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"635_CR19","first-page":"354","volume":"8","author":"GM Owens","year":"2015","unstructured":"Owens GM. Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment. Am Health Drug Benefits. 2015;8(7):354\u201360. PubMed PMID: 26557229; PubMed Central PMCID: PMC4636274.","journal-title":"Am Health Drug Benefits"},{"issue":"2","key":"635_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/03009742.2020.1794028","volume":"50","author":"SY Kawashiri","year":"2021","unstructured":"Kawashiri SY, Nishino A, Shimizu T, Takatani A, Umeda M, Koga T, et al. Fluorescence optical imaging in patients with active rheumatoid arthritis: a comparison with ultrasound and an association with biomarkers. Scand J Rheumatol. 2021;50(2):95\u2013103. 1794028. PubMed PMID: 33084461.","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"635_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/rheumatology\/keab377","volume":"61","author":"M Ammitzb\u00f8ll-Danielsen","year":"2022","unstructured":"Ammitzb\u00f8ll-Danielsen M, Glinatsi D, Terslev L, \u00d8stergaard M. A novel fluorescence optical imaging scoring system for hand synovitis in rheumatoid arthritis-validity and agreement with ultrasound. Rheumatology (Oxford). 2022;61(2):636\u201347. https:\/\/doi.org\/10.1093\/rheumatology\/keab377. PubMed PMID: 33890623.","journal-title":"Rheumatology (Oxford)"},{"key":"635_CR22","doi-asserted-by":"publisher","unstructured":"Ohrndorf S, Glimm AM, Ammitzb\u00f8ll-Danielsen M, Ostergaard M, Burmester GR. Fluorescence optical imaging: ready for prime time? RMD Open. 2021;7(2). https:\/\/doi.org\/10.1136\/rmdopen-2020-001497. PubMed PMID: 34088778; PubMed Central PMCID: PMC8183208.","DOI":"10.1136\/rmdopen-2020-001497"},{"issue":"9","key":"635_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/acr2.11599","volume":"5","author":"Y Kisten","year":"2023","unstructured":"Kisten Y, Arnaud L, Levitsky A, Gy\u00f6ri N, Larsson P, Hensvold A, et al. Distinct Fluorescence Optical Imaging Patient Clusters Emerge for Seropositive and Seronegative Rheumatoid Arthritis. ACR Open Rheumatol. 2023;5(9):474\u201380. https:\/\/doi.org\/10.1002\/acr2.11599. Epub 20230807.","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"635_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13075-022-02795-w","volume":"24","author":"S Hertrampf","year":"2022","unstructured":"Hertrampf S, Klotsche J, Schefer Q, Glimm AM, Burmester GR, Hoff P, et al. Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNF\u03b1 therapy. Arthritis Res Ther. 2022;24(1):117. https:\/\/doi.org\/10.1186\/s13075-022-02795-w. Epub 20220521.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"635_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13075-019-1989-5","volume":"21","author":"AM Glimm","year":"2019","unstructured":"Glimm AM, Sprenger LI, Haugen IK, Mansmann U, Hermann S, H\u00e4upl T, et al. Fluorescence optical imaging for treatment monitoring in patients with early and active rheumatoid arthritis in a 1-year follow-up period. Arthritis Res Ther. 2019;21(1):209. https:\/\/doi.org\/10.1186\/s13075-019-1989-5. Epub 20190918.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"635_CR26","doi-asserted-by":"publisher","first-page":"e047713","DOI":"10.1136\/bmjopen-2020-047713","volume":"11","author":"SL Ridha Ali","year":"2021","unstructured":"Ridha Ali SL, Glimm AM, Burmester GR, Hoff P, Schmittat G, Hermann S, et al. Is the fluorescence optical imaging (FOI) able to discriminate between rheumatoid arthritis patients with and without need of rituximab retherapy? A cohort study. BMJ Open. 2021;11(8):e047713. https:\/\/doi.org\/10.1136\/bmjopen-2020-047713. Epub 20210803.","journal-title":"BMJ Open"},{"key":"635_CR27","doi-asserted-by":"publisher","unstructured":"Triantafyllias K, Clasen M, De Blasi M, Berres M, Nikolodimos E, Schwarting A. Performance of a novel high-resolution infrared thermography marker in detecting and assessing joint inflammation: a comparison with joint ultrasound. Clin Exp Rheumatol. 2024;42(9):1802-11. Epub 20240501. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ne4k8y. PubMed PMID: 38757297.","DOI":"10.55563\/clinexprheumatol\/ne4k8y"},{"issue":"7","key":"635_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/ard.44.7.434","volume":"44","author":"MD Devereaux","year":"1985","unstructured":"Devereaux MD, Parr GR, Thomas DP, Hazleman BL. Disease activity indexes in rheumatoid arthritis; a prospective, comparative study with thermography. Ann Rheum Dis. 1985;44(7):434\u20137. https:\/\/doi.org\/10.1136\/ard.44.7.434. PubMed PMID: 4026404; PubMed Central PMCID: PMC1001672.","journal-title":"Ann Rheum Dis"},{"key":"635_CR29","doi-asserted-by":"publisher","unstructured":"Morales-Ivorra I, Narv\u00e1ez J, G\u00f3mez-Vaquero C, Moragues C, Nolla JM, Narv\u00e1ez JA, et al. Assessment of inflammation in patients with rheumatoid arthritis using thermography and machine learning: a fast and automated technique. RMD Open. 2022;8(2). https:\/\/doi.org\/10.1136\/rmdopen-2022-002458. PubMed PMID: 35840312; PubMed Central PMCID: PMC9295660.","DOI":"10.1136\/rmdopen-2022-002458"},{"issue":"8","key":"635_CR30","doi-asserted-by":"publisher","first-page":"081420","DOI":"10.1117\/1.JBO.17.8.081420","volume":"17","author":"AJ Meier","year":"2012","unstructured":"Meier AJ, Rensen WH, de Bokx PK, de Nijs RN. Potential of optical spectral transmission measurements for joint inflammation measurements in rheumatoid arthritis patients. J Biomed Opt. 2012;17(8):081420. https:\/\/doi.org\/10.1117\/1.Jbo.17.8.081420. PubMed PMID: 23224181.","journal-title":"J Biomed Opt"},{"issue":"3","key":"635_CR31","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/annrheumdis-2015-208399","volume":"75","author":"S Krabbe","year":"2016","unstructured":"Krabbe S, Ammitzb\u00f8ll-Danielsen M, \u00d8stergaard M, Giard MC, Terslev L. Sensitivity and specificity of optical spectral transmission imaging in detecting joint inflammation in rheumatoid arthritis. Ann Rheum Dis. 2016;75(3):632\u20133. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208399. Epub 20151113.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"635_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12891-024-07472-4","volume":"25","author":"C Rinkin","year":"2024","unstructured":"Rinkin C, Malaise O, Chauveheid F, Gerard C, Seidel L, Malaise M, et al. Optical imaging (HandScan) can identify ultrasound remission in rheumatoid arthritis. BMC Musculoskelet Disord. 2024;25(1):361. https:\/\/doi.org\/10.1186\/s12891-024-07472-4. Epub 20240507.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"635_CR33","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/acr.24607","volume":"74","author":"MMA Verhoeven","year":"2022","unstructured":"Verhoeven MMA, Westgeest AAA, Schwarting A, Jacobs JWG, Heller C, van Laar JM, et al. Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores. Arthritis Care Res (Hoboken). 2022;74(9):1493\u20139. https:\/\/doi.org\/10.1002\/acr.24607. Epub 20220618.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"635_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13075-025-03478-y","volume":"27","author":"K Triantafyllias","year":"2025","unstructured":"Triantafyllias K, Alhaddad M, Schwarting A, Balaklytska V, Baraliakos X. Diagnostic performance of optical spectral transmission compared to magnetic resonance imaging in patients with inflammatory arthritis. Arthritis Res Ther. 2025;27(1):17. https:\/\/doi.org\/10.1186\/s13075-025-03478-y. Epub 20250130.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"635_CR35","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3899\/jrheum.190650","volume":"47","author":"K Triantafyllias","year":"2020","unstructured":"Triantafyllias K, Heller C, de Blasi M, Galle PR, Schwarting A. Diagnostic Value of Optical Spectral Transmission in Rheumatoid Arthritis: Associations with Clinical Characteristics and Comparison with Joint Ultrasonography. J Rheumatol. 2020;47(9):1314\u201322. https:\/\/doi.org\/10.3899\/jrheum.190650. Epub 20200401.","journal-title":"J Rheumatol"},{"issue":"1","key":"635_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13075-024-03400-y","volume":"26","author":"K Triantafyllias","year":"2024","unstructured":"Triantafyllias K, Altamimi KK, Schederecker F, Schwarting A. Increased predictive value of optical spectral transmission in early rheumatoid arthritis through use of patient-adjusted cut-off scores. Arthritis Res Ther. 2024;26(1):165. https:\/\/doi.org\/10.1186\/s13075-024-03400-y. Epub 20240920.","journal-title":"Arthritis Res Ther"},{"key":"635_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. Epub 20210329. https:\/\/doi.org\/10.1136\/bmj.n71. PubMed PMID: 33782057; PubMed Central PMCID: PMC8005924."},{"issue":"2","key":"635_CR38","doi-asserted-by":"publisher","first-page":"e0209761","DOI":"10.1371\/journal.pone.0209761","volume":"14","author":"NJ Besselink","year":"2019","unstructured":"Besselink NJ, Jacobs JWG, Westgeest AAA, van der Meijde P, Welsing PMJ, Marijnissen ACA, et al. Can optical spectral transmission assess ultrasound-detected synovitis in hand osteoarthritis? PLoS ONE. 2019;14(2):e0209761. https:\/\/doi.org\/10.1371\/journal.pone.0209761. Epub 20190222.","journal-title":"PLoS ONE"},{"key":"635_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf007","author":"K Triantafyllias","year":"2025","unstructured":"Triantafyllias K, Alhaddad M, Baraliakos X, Muthuraman M, Schwarting A. Optical spectral transmission to monitor disease activity in arthritis patients: longitudinal follow-up comparison with clinical parameters. Rheumatology (Oxford). 2025. https:\/\/doi.org\/10.1093\/rheumatology\/keaf007. Epub 20250103.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"635_CR40","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00296-021-05060-6","volume":"42","author":"AA Hasan","year":"2022","unstructured":"Hasan AA, Reimann F, Veeger N, Bergstra SA, Zhang D, Bourgonje AR, et al. Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry. Rheumatol Int. 2022;42(11):2019\u201326. https:\/\/doi.org\/10.1007\/s00296-021-05060-6. Epub 20220127.","journal-title":"Rheumatol Int"},{"key":"635_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf480","author":"K Triantafyllias","year":"2025","unstructured":"Triantafyllias K, Liverakos S, Baraliakos X, Schwarting A. Inflammation assessment in psoriatic arthritis via optical spectral transmission: correlations with clinical markers and musculoskeletal ultrasound. Rheumatology (Oxford). 2025. https:\/\/doi.org\/10.1093\/rheumatology\/keaf480. Epub 20250911.","journal-title":"Rheumatology (Oxford)"},{"key":"635_CR42","unstructured":"Demcon. Hemics HandScan device. Available from: https:\/\/demcon.com\/corporate\/hemics."},{"issue":"2","key":"635_CR43","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/ar1904","volume":"8","author":"M Szkudlarek","year":"2006","unstructured":"Szkudlarek M, Klarlund M, Narvestad E, Court-Payen M, Strandberg C, Jensen KE, et al. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Therapy. 2006;8(2):R52. https:\/\/doi.org\/10.1186\/ar1904.","journal-title":"Arthritis Res Therapy"},{"issue":"7","key":"635_CR44","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/rheumatology\/kez460","volume":"59","author":"B M\u00f6ller","year":"2020","unstructured":"M\u00f6ller B, Aletaha D, Andor M, Atkinson A, Aubry-Rozier B, Brulhart L, et al. Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years. Rheumatology (Oxford). 2020;59(7):1556\u201365. https:\/\/doi.org\/10.1093\/rheumatology\/kez460. PubMed PMID: 31630207; PubMed Central PMCID: PMC7310093.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"635_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3899\/jrheum.131027","volume":"41","author":"MN Witt","year":"2014","unstructured":"Witt MN, Mueller F, Weinert P, Nigg AP, Reindl CS, Proft F, et al. Ultrasound of synovitis in rheumatoid arthritis: advantages of the dorsal over the palmar approach to finger joints. J Rheumatol. 2014;41(3):422\u20138. https:\/\/doi.org\/10.3899\/jrheum.131027. Epub 20140201.","journal-title":"J Rheumatol"},{"issue":"6","key":"635_CR46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.berh.2004.05","volume":"18","author":"WA Schmidt","year":"2004","unstructured":"Schmidt WA. Doppler sonography in rheumatology. Best Pract Res Clin Rheumatol. 2004;18(6):827\u201346. https:\/\/doi.org\/10.1016\/j.berh.2004.05.003. PubMed PMID: 15501185.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"635_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1745-6215-8-38","volume":"8","author":"P Tugwell","year":"2007","unstructured":"Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials. 2007;8:38. https:\/\/doi.org\/10.1186\/1745-6215-8-38. Epub 20071126.","journal-title":"Trials"},{"issue":"4","key":"635_CR48","first-page":"848","volume":"34","author":"RJ Wakefield","year":"2007","unstructured":"Wakefield RJ, D\u2019Agostino MA, Iagnocco A, Filippucci E, Backhaus M, Scheel AK, et al. The OMERACT Ultrasound Group: status of current activities and research directions. J Rheumatol. 2007;34(4):848\u201351. PubMed PMID: 17407236.","journal-title":"J Rheumatol"},{"issue":"3","key":"635_CR49","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/annrheumdis-2015-207315","volume":"75","author":"M van Onna","year":"2016","unstructured":"van Onna M, Ten Cate DF, Tsoi KL, Meier AJ, Jacobs JW, Westgeest AA, et al. Assessment of disease activity in patients with rheumatoid arthritis using optical spectral transmission measurements, a non-invasive imaging technique. Ann Rheum Dis. 2016;75(3):511\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207315. Epub 20151009.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"635_CR50","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3899\/jrheum.201555","volume":"48","author":"MMA Verhoeven","year":"2021","unstructured":"Verhoeven MMA, Westgeest AAA, Jacobs JWG. A Sex Difference in HandScan Scores in Rheumatoid Arthritis Patients and Controls? An Ongoing Analysis of the Sex Difference and Other Potential Confounders. J Rheumatol. 2021;48(6):950\u20131. https:\/\/doi.org\/10.3899\/jrheum.201555. Epub 20210315.","journal-title":"J Rheumatol"},{"key":"635_CR51","doi-asserted-by":"publisher","unstructured":"Triantafyllias K, Heller C, de Blasi M, Galle PR, Schwarting A, Dr. Triantafyllias, et al. reply. J Rheumatol. 2021;48(6):951. Epub 20210315. https:\/\/doi.org\/10.3899\/jrheum.201636. PubMed PMID: 33722943.","DOI":"10.3899\/jrheum.201636"},{"issue":"8","key":"635_CR52","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373. 10.1002. \/art.21972. PubMed PMID: 16871531.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"635_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jacr.2007.07.016","volume":"5","author":"L Parker","year":"2008","unstructured":"Parker L, Nazarian LN, Carrino JA, Morrison WB, Grimaldi G, Frangos AJ, et al. Musculoskeletal imaging: medicare use, costs, and potential for cost substitution. J Am Coll Radiol. 2008;5(3):182\u20138. https:\/\/doi.org\/10.1016\/j.jacr.2007.07.016. PubMed PMID: 18312965.","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"635_CR54","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00296-021-05026-8","volume":"42","author":"R Wolkorte","year":"2022","unstructured":"Wolkorte R, Heesink L, Kip MMA, Koffijberg H, Tabak M, Gr\u00fcnloh C. Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device. Rheumatol Int. 2022;42(9):1565\u201372. https:\/\/doi.org\/10.1007\/s00296-021-05026-8. Epub 20211021.","journal-title":"Rheumatol Int"},{"key":"635_CR55","doi-asserted-by":"publisher","unstructured":"Verhoeven MMA, Westgeest AAA, Tekstra J, van Laar JM, Lafeber F, Welsing PMJ, et al. Classification of rheumatoid arthritis into active or inactive with a modified disease activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts. Clin Exp Rheumatol. 2022;40(11):2018-22. Epub 20220217. https:\/\/doi.org\/10.55563\/clinexprheumatol\/tpsngs. PubMed PMID: 35200120.","DOI":"10.55563\/clinexprheumatol\/tpsngs"},{"issue":"2","key":"635_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/03009742.2023.2177382","volume":"53","author":"AB Blanken","year":"2024","unstructured":"Blanken AB, Korteweg M, van Boheemen L, van Vollenhoven RF, Nurmohamed MT, van der Laken CJ. Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis. Scand J Rheumatol. 2024;53(2):85\u201393. PubMed PMID: 36974977.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"635_CR57","doi-asserted-by":"publisher","first-page":"rkab004","DOI":"10.1093\/rap\/rkab004","volume":"5","author":"MMA Verhoeven","year":"2021","unstructured":"Verhoeven MMA, Tekstra J, Marijnissen ACA, Meier AJL, Westgeest AAA, Lafeber F, et al. Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study. Rheumatol Adv Pract. 2021;5(1):rkab004. https:\/\/doi.org\/10.1093\/rap\/rkab004. Epub 20210128.","journal-title":"Rheumatol Adv Pract"},{"issue":"9","key":"635_CR58","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1093\/rheumatology\/keab435","volume":"60","author":"L van Boheemen","year":"2021","unstructured":"van Boheemen L, Blanken A, Kuin A, van Schaardenburg D. No added value of optimal spectral transmission imaging in persons at risk of rheumatoid arthritis. Rheumatology (Oxford). 2021;60(9):4436\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keab435. PubMed PMID: 33983434.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"635_CR59","doi-asserted-by":"publisher","first-page":"rkaf106","DOI":"10.1093\/rap\/rkaf106","volume":"9","author":"MS van der Leeuw","year":"2025","unstructured":"van der Leeuw MS, Welsing PMJ, Tekstra J, Westgeest AAA, Klaasen R, Gamala M, et al. HandScan criteria versus ACR\/EULAR Boolean remission as treatment target in early rheumatoid arthritis: results of a randomized controlled trial. Rheumatol Adv Pract. 2025;9(4):rkaf106. https:\/\/doi.org\/10.1093\/rap\/rkaf106. Epub 20250915.","journal-title":"Rheumatol Adv Pract"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00635-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00635-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00635-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:23:50Z","timestamp":1781641430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00635-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00635-x","relation":{"references":[{"id-type":"doi","id":"10.1136\/bmj.n71","asserted-by":"subject"}]},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}